Study: Leafy Greens OK For People on Warfarin
The results of the small study suggest that taking in more vitamin K, not less, might help patients on warfarin (Coumadin). (Source: WebMD Health)
Source: WebMD Health - June 11, 2019 Category: Consumer Health News Source Type: news
Vitamin K Can Up Anticoagulation Stability in Patients on Warfarin
TUESDAY, June 11, 2019 -- Increasing vitamin K (VK) intake through dietary strategies improves the anticoagulation stability of warfarin-treated patients, according to a study presented during Nutrition 2019, the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 11, 2019 Category: Pharmaceuticals Source Type: news
Study Refutes Notion That People on Warfarin Shouldn't Eat Leafy Greens
TUESDAY, June 11, 2019 -- Spinach-loving seniors, rejoice. A new study suggests that -- despite doctor warnings to the contrary -- you can eat leafy greens rich in vitamin K if you are taking the blood thinner warfarin.
In fact, " I think all... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 11, 2019 Category: General Medicine Source Type: news
Boston Sci Initiates New Watchman FLX Study
Boston Scientific has initiated a study that will compare the Watchman FLX left atrial appendage (LAA) closure device’s safety and effectiveness to that of anticoagulants for reducing stroke risk in atrial fibrillation patients in a new trial.
The randomized, controlled OPTION trial will enroll 1,600 patients with non-valvular AFib who are suitable for oral anticoagulants (OAC) therapy and have recently had or will have an ablation. Patients at as many as 130 global sites will be randomized to receive the newest-generation Watchman FLX device or an OAC, inclusive of commonly prescribed direct oral anticoa...
Source: MDDI - May 24, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news
Clinically Relevant Drug-Drug Interactions in Primary Care Clinically Relevant Drug-Drug Interactions in Primary Care
Review common and predictable drug interactions associated with antimicrobials, warfarin, amiodarone, antihypertensives, and opioids.American Family Physician (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Low-Dose Aspirin Linked To Bleeding In The Skull, New Report Says
(CNN) — Taking low-dose aspirin to prevent heart disease and stroke is associated with an increased risk of bleeding in the skull in people without a history of those conditions, according to a new report.
Researchers analyzed data from 13 previous studies in which over 130,000 people ages 42 to 74, who didn’t have a history of heart disease or stroke, were given either aspirin or a placebo for the prevention of these conditions. All the trials reported on the risk of head bleeding.
People who took the placebo had a 0.46% risk of having a head bleed during the combined trial periods. For those who took aspirin,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 13, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news
Independent large real-world study comparing NOACs in AF-patients
The results from an independent retrospective comparative study, published in January 2019 in the American Journal of Medicine, showed that dabigatran was associated with a more favourable benefit-harm profile than both warfarin and rivaroxaban. (Source: World Pharma News)
Source: World Pharma News - April 16, 2019 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news
Real-world-study-comparing-NOACs-in-AF-patients
Independent large real-world study comparing NOACs in AF-patientsA recently published large retrospective comparative study investigated stroke, bleeding and mortality risks in older US Medicare patients treated with commonly marketed oral anticoagulants for non-valvular atrial fibrillation1 Results of the real-world study showed that Pradaxa ® (dabigatran etexilate) was associated with a more favourable benefit-risk profile in comparison to both warfarin and rivaroxaban1Data from an earlier FDA-funded Medicare study published in 2015, which investigated cardiovascular, bleeding and mortality risks among patients treate...
Source: Boehringer Ingelheim Corporate News - April 15, 2019 Category: Research Source Type: news
FDA warns about risks of using home use test strips that are pre-owned or not authorized for sale in U.S., including those for glucose, warfarin
(Source: Food and Drug Administration)
Source: Food and Drug Administration - April 8, 2019 Category: American Health Source Type: news
Daily Aspirin No Longer Recommended To Prevent Heart Attacks In Older Adults
(CNN) — If you’re a healthy older adult looking for ways to reduce your risk of heart attack and stroke, don’t turn to that age-old standby: daily low-dose aspirin. It’s no longer recommended as a preventative for older adults who don’t have a high risk or existing heart disease, according to guidelines announced Sunday by the American College of Cardiology and the American Heart Association.
“For the most part, we are now much better at treating risk factors such as hypertension, diabetes and especially high cholesterol,” said North Carolina cardiologist Dr. Kevin Campbell, who wa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news
XARELTO ® (rivaroxaban) Significantly Reduced the Risk of Overall Strokes and the Most Severe Strokes and Was Associated with Fewer Stroke-Related Deaths in the Real World Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation
(Source: Johnson and Johnson)
Source: Johnson and Johnson - March 18, 2019 Category: Pharmaceuticals Source Type: news
Direct Oral Anticoagulants of Benefit in Afib With Mitral Stenosis (CME/CE)
(MedPage Today) -- DOACs linked with lower rates of thromboembolism than warfarin and just as effective in preventing hemorrhagic strokes (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 17, 2019 Category: Urology & Nephrology Source Type: news
AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI
The most safe and effective antithrombotic regimen may involve neither warfarin nor aspirin, suggested a trial that might allay bleeding-risk concerns in a tough-to-treat atrial fibrillation population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 17, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
DOACs Promising for Afib Patients With Mitral Stenosis
(MedPage Today) -- Warfarin not necessarily the go-to therapy, Korean study finds (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 11, 2019 Category: Cardiology Source Type: news
Doubling up on blood thinners increases risk for excessive bleeding
Patients who use an anticoagulant such as warfarin should be careful if they are also on an aspirin regimen as it can increase the risk for excessive bleeding, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 4, 2019 Category: Consumer Health News Source Type: news
